Alexandra Cellucci was 28 when she was diagnosed with neurofibromatosis, a rare genetic disease that causes noncancerous tumors to growon thebody's nervous tissues. She was also eight months pregnant at the time, but she would eventually delivera healthy baby girl.
Neurofibromatosis,known as NF for short,runs in Cellucci'sfamily, so sheknew her daughter could have the diseaseand she could pass it on to futurechildren. So sheand her husband, Marc, used reproductive medicine to conceive another baby, hadthe embryostested for the gene that causes NFand had doctors implantembryos in her womb without the mutatedgene.
Alex Cellucci, 35, rubs fabric on her right eye, where she had a tumor removed the previous day, while watching a movie with her daughter, Maible, 6, at their home in Quincy, Mass. on Tuesday, Aug. 6, 2019. Alex and Maible both have neurofibromatosis, a genetic disorder that causes tumors to form on nerve tissue. Alex was diagnosed with neurofibromatosis type 2 at age 28 and has since endured two MRI scans every year to monitor tumors.(Photo: Nic Antaya, Special to The Detroit News)
Cellucci, now 35, never got pregnant again, despite many attempts. She and her husband have since learned their daughter Maible, now6,also carriesthe gene for NF2, one of the three forms of the disease. The day before Maible's birthday last November,the girl asked if she had the disease. Cellucci said she told her yes and that she would be OK.
That's why the Massachusetts coupledonated seven embryos with the NF2 gene to the University of Michigan soresearchers could create an embryonic stem cell line that other researchers could study, with the hope of one day discovering a breakthrough. In a perfect world, such a development would come before their daughter endures any symptoms.
Alex Cellucci, 35, poses for a portrait at her home in Quincy, Mass. on Tuesday, Aug. 6, 2019. Alex and her 6-year-old daughter, Maible, both have neurofibromatosis, a genetic disorder that causes tumors to form on nerve tissue.(Photo: Nic Antaya, Special to The Detroit News)
I just wanted hope," said Cellucci, who had surgery last monthto remove a benigntumorbehind her eye. "They could possibly find a cure for (Maible) ... and offer hope for other families."
UM researchers have turned the Celluccis' embryos intothe firststem cell line that models NF2, which is one of the more rare forms of the disease. Besides the tumor growth, NF2 comes with a host of issues, including hearing loss, ringing in the ears and loss of balance. Symptoms typically appear in the teen years.
The embryonic stem cell line modeling the disease, created by ProfessorGary Smith, director ofthe MStem Cell Laboratories,has been acceptedonto the National Institutes of Health Human Embryonic Stem Cell Registryforother scientists to study and make discoveries around interventions anda possible cure. Another line also is under review.
Alex Cellucci, 35, watches a movie at her home in Quincy, Mass., a day after having a tumor removed from behind her right eye.(Photo: Nic Antaya, Special to The Detroit News)
Researchers can apply to access the stem cell lines on thefederal registryto study how diseases form and develop, with the aim of finding ways to better understand, treat, delay and possibly even cure diseases.
Smith has derived all of UM's56embryonic stem cell lines on the national registry, including 36 disease-specific lines. Hesaid the personal stories behind all of those stem cell lines are important.
"We just don't do science to do science," Smith said. "We do science to help others. Here is a family that recognizes that. Sometimes that gets lost on people. ... We really do want to help people."
The NF2 stem cell line comes as neurofibromatosis scientists andclinicians prepare to gather next month for their annual conference in San Francisco.
Alex Cellucci, 35, and her daughter, Maible, 6, watch a movie at their home in Quincy, Mass. on Tuesday, Aug. 6, 2019. Alex and Maible both have neurofibromatosis, a genetic disorder that causes tumors to form on nerve tissue. Alex was diagnosed with neurofibromatosis type 2 at age 28 and has since had two MRI scans done every year to monitor tumors. Most recently, Alex had a tumor removed behind her right eye on Aug. 5, 2019.(Photo: Nic Antaya, Special to The Detroit News)
It also comes as Detroitbusinessman andCleveland Cavaliers ownerDan Gilbert has used philanthropy to support the small research community of neurofibromatosis. His 23-year-old son, Nick, was born with neurofibromatosis type 1.
NF2 afflicts1 in 33,000 people worldwide, while NF1 is more common, occurringin 1 in 3,000 to 4,000 people, according to the National Institutes of Health. NF1 typically begins in childhood and leads to skin changes and bone deformity.Schwannomatosis, the rarest type of NF, causes intense pain.
Gilbert, who suffered a stroke in late May,has spoken about neurofibromatosis and also about howNick, a Michigan State University student, hadto undergobrain surgery in 2018 to remove tumors.
Gilbert, a billionaire, has invested $64 million over the yearsthrough the Gilbert Family Foundation, including $12 million for gene therapy initiatives to address the underlying cause of NF1 and $11 million for vision loss in NF1 patients, which Nick grapples with, according toYooRi Kim, the foundation's scientific officer.
Marc and Alex Cellucci, and their daughter, Maible, 6, and dog Pedalino, pose for a portrait outside of their home in Quincy, Mass. on Tuesday, Aug. 6, 2019. Alex and Maible both have neurofibromatosis, a genetic disorder that causes tumors to form on nerve tissue.(Photo: Nic Antaya, Special to The Detroit News)
"With deeper understanding with each of these diseases that we've obtained over time, it's becoming more and more clear that the strategies that you would use to help each of thosepatients are going to look different," Kim said.
Even so, she said there is excitement about advances in research on other forms of NF, such as the stem cell line modeling NF2.
There arefour embryonic stem cell lines on the registry that model NF1, but theline UM created is the first for the research community studying NF2,according to Smith.
"It means a lot to the couplethat somebody is using something that otherwise would have been discarded and instead trying to make it something that can be used worldwide to understand this disease better," he said.
The stem cell line hasbeen applauded by Sally Temple, scientific director of the Neural Stem Cell Institute in Rensselaer,New York, which uses stem cell technologies to develop therapies that affect the nervous system.
Alex Cellucci, 35, and her daughter, Maible, 6, pose for a portrait outside of their home in Quincy, Mass. on Tuesday, Aug. 6, 2019. Alex and Maible, both have neurofibromatosis, a genetic disorder that causes tumors to form on nerve tissue.(Photo: Nic Antaya, Special to The Detroit News)
"It's a really wonderful and generous for the parents to do," said Temple, who is also aUM adjunct professor in the ophthalmology department. "When you make these human embryonic stem cell lines, they are essentially a resource forever for the community. It's available and it will be there for (researchers)to use forever in the future. It's not a one-time donation."
She added that this is important for the NF2 community since it is such a devastating disease.
Marc Cellucci is beyond thrilled, and hopeful of the possibilities for the stem cell line that he and his wife helped create and what it could do for his daughter, wife, in-laws and so many others with NF.
It all has to start somewhere, said Cellucci,where the scientific breakthroughs happen, and the miracles begin.
- Harvard geneticist George Church's goal: to protect humans from viruses, genetic diseases, and aging - 60 Minutes - CBS News - December 8th, 2019
- Start-up to research on degenerative eye disease - Deccan Herald - December 8th, 2019
- R&D Activities to Fast-track the Growth of the Stem Cell Assay Market Between 2018 2028 - Kentucky Reports - December 8th, 2019
- The Making of a Root - Duke Today - December 5th, 2019
- Engelhardt named 2019 Fellow of the National Academy of Inventors - Iowa Now - December 5th, 2019
- In the Spotlight: 'When you're in a minority group, you're never just a grad student' - Scope - December 5th, 2019
- Rat Model Market revenue to hit $1.8 billion by 2025: Global Market Insights, Inc. - GlobeNewswire - December 5th, 2019
- Dosage analysis of the 7q11.23 Williams region identifies BAZ1B as a major human gene patterning the modern human face and underlying... - December 5th, 2019
- Stem Cell Banking Market expected to Witness a Sustainable Growth over 2028 - VaporBlash - December 5th, 2019
- Stem Cell Media Market 2019 Global Industry Insights, Innovations, Key Players Analysis, Growth Strategies and Forecast Analysis 2019 & 2026|... - December 5th, 2019
- Adult Stem Cells- Global Healthcare Research and Survey with Key Participants Celyad, Cytori Therapeutics Inc. - Planet InfoWar - December 5th, 2019
- Stem Cell Source Market 2019, Trend, CAGR Status, Growth, Analysis and Forecast to 2024 - VaporBlash - December 5th, 2019
- Global Stem Cell Therapy Contract Manufacturing Market Research 2019-2030: Source of Stem Cells, Types of Stem Cells, Size of Contract Service... - December 3rd, 2019
- New Stem Cell Research Could Make Cancer Treatments affordable and Effective for Hospitals and Patients - PRNewswire - December 3rd, 2019
- Fat grafting improves range of motion in limbs damaged by radiation therapy - Yahoo Finance - December 3rd, 2019
- Induced Pluripotent Stem Cells Market To Register High Revenue Growthat 7% CAGR Throughout 2018 to 2026 - Kentucky Reports - December 3rd, 2019
- Animal Stem Cell Therapy Market forecasted to surpass the value of ~US$ XX Mn/Bn by 2017 - 2025 - The Market Expedition - December 3rd, 2019
- Stem Cell Assay Market Estimated to Record Highest CAGR by 2017 - 2025 - The Market Expedition - December 3rd, 2019
- Autologous Stem Cell and Non Stem Based therapies Market Size SWOT Analysis of Top Key Player Forecasts To 2025 - Markets Gazette 24 - December 3rd, 2019
- Global Stem Cell Banking Storage Market 2019 by Company, Regions, Type and Application, Forecast to 2025 - Industry News Info - December 3rd, 2019
- Stem Cell Banking Market to Witness an Outstanding Growth by 2018 - 2026 - Weekly Spy - December 3rd, 2019
- Stem Cell Banking Market Advanced technologies & growth opportunities in global Industry by 2018 - 2026 - Markets Gazette 24 - December 3rd, 2019
- Global Stem Cell Banking Market with Geographic Segmentation, Demand by Regions, Statistical Forecast and Competitive Landscape Research upto... - November 30th, 2019
- How Flight Feathers Evolved: Study of Chickens, Ostriches, Penguins, Ducks and Eagles - SciTechDaily - November 30th, 2019
- Researchers discover a stem cell therapy that can help heal injured heart - ANI News - November 29th, 2019
- Revolutionizing Injury Recovery With Tendon Stem Cells - Technology Networks - November 29th, 2019
- How birds fly: New USC study examines the evolution of flight feathers - USC News - November 29th, 2019
- New Link Discovered Between Cells That Burn Fat and Colon Cancer - Clinical OMICs News - November 29th, 2019
- Systematic analysis and evaluation of Mesenchymal Stem Cells Market with share, growth rate, Forecasts to 2026 - WindStreetz - November 29th, 2019
- New Device Permits a Closer Look at Previously Inaccessible Areas of the Genome - Technology Networks - November 25th, 2019
- Omega 3 Fatty Acid Health Welfare Connected To Stem Cell Regulation Researchers Discover - News Raise - November 22nd, 2019
- Tokyo's Heartseed reaps $26M to test its stem cell injections for heart failure - FierceBiotech - November 22nd, 2019
- Junior Research Fellow for Stem Cell-Based Neural Tissue Engineering Project job with VELLORE INSTITUTE OF TECHNOLOGY | 187070 - Times Higher... - November 22nd, 2019
- CRISPR Therapeutics and Vertex: Promising Gene Therapy Data for Sickle Cell Disease and Beta Thalassemia - BioSpace - November 22nd, 2019
- Europe Stem Cell Assay Market to Witness a Pronounce Growth in Coming Years | Insights, Trends, Growth, Industry Drivers with Cellular Dynamics... - November 22nd, 2019
- Stem Cell And Regenerative Therapy Market Value Share, Analysis and Segments 2018-2024 - Crypto News Byte - November 22nd, 2019
- Global Stem Cell Antibody Market: Key companies Profile, their market Share and other important parameters - Market Research Reporting - November 22nd, 2019
- Animal Stem Cell Therapy Market Application, Specification Analysis, Size and Growth 2019 To 2024 - VaporBlash - November 22nd, 2019
- Stem Cell Media Market 2019| Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2026 | Research Industry US - News Obtain - November 17th, 2019
- International Stem Cell Corporation Announces Financial Results for the Three and Nine-Months ended September 30, 2019 - Yahoo Finance - November 17th, 2019
- Quality of Life With Busulfan and Fludarabine Compared With Busulfan and Cyclophosphamide - Hematology Advisor - November 17th, 2019
- Bioethics Coming to Elementary and High Schools? - Discovery Institute - November 17th, 2019
- 'Dr. Death' and 'Bad Batch' Host Laura Beil on the Future of Podcasts - ELLE.com - November 17th, 2019
- Leading Alternative Healing Director of Total Health Institute Reviews and Receives 3rd Fellowship in Stem Cell Therapy - GlobeNewswire - November 15th, 2019
- NIST researchers use artificial intelligence for quality control of stem cell-derived tissues - National Institutes of Health - November 15th, 2019
- BREAKTHROUGH: Her vision was getting worse, then animal research made things clear - Speaking of Research - November 15th, 2019
- Stem Cell Therapy Market To Increase Exponentially During 2018 2025 - Downey Magazine - November 15th, 2019
- Stem Cell Transplants Used to Grow Fully Functional Lungs in Mice - Technology Networks - November 11th, 2019
- Human Heart Cells Transform in Space; Return to Normal on Earth: Study - The Weather Channel - November 11th, 2019
- Serving those who serve us - The Hub at Johns Hopkins - November 11th, 2019
- Kadimastem to Present Interim Results of Cohort A of Its Phase 1/2a Clinical Trial in ALS at the 7th International Stem Cell Meeting, in Tel-Aviv,... - November 11th, 2019
- The Value and Versatility of Clinical Flow Cytometry - Technology Networks - November 11th, 2019
- Global Cell Harvesting Industry Research: Key Companies Profile with Sales, Revenue, Market Share, Price and Competitive Situation Analysis - Inquiry... - November 11th, 2019
- Human heart cells are altered by spaceflight, but return mostly to normal on Earth - Space Daily - November 9th, 2019
- Jennifer OConnell: President Kanye in 2024? Be very afraid America - The Irish Times - November 9th, 2019
- Global Animal Stem Cell Therapy Market - Industry Outlook and Forecast 2019-2024 - Real Viewpoint - November 9th, 2019
- Novel Molecule Reduces the Aggressiveness of Pediatric Cancer - Technology Networks - November 7th, 2019
- 2019s Allen Distinguished Investigators will focus on the mysteries of our cells - Yahoo Tech - November 7th, 2019
- At the American Academy of Stem Cell Physicians Live Congress 2019, FDA Safety Panel Says No to the Bad Actors - PRNewswire - November 7th, 2019
- MD Anderson Partners with Takeda to Develop CAR Natural Killer-Cell Therapy - Cancer Network - November 7th, 2019
- First UK patient treated with tissue engineered product for rare eye disease - Hospital Healthcare Europe - November 7th, 2019
- Spaceflight alters heart cells but they quickly recover back on Earth - New Scientist News - November 7th, 2019
- Stem Cell Assay Market To Witness Increase In Revenues By 2024 - Montana Ledger - November 7th, 2019
- Researchers Find Link Between Eye Disease And Degeneration Of The Brain - BioSpace - November 7th, 2019
- Physicians' Education Resource to Host Satellite Symposia at Annual American Society of Hematology Meeting and Exposition in Orlando - Business Wire - November 7th, 2019
- Keep Bioethics out of Elementary and High Schools - National Review - November 7th, 2019
- Stem Cell Cartilage Regeneration Market 2019, Trend, CAGR Status, Growth, Analysis and Forecast to 2025 - Virtualnewsusa - November 7th, 2019
- The Bold and the Beautiful Star Don Diamont Supports ALS Research - Soap Hub - November 7th, 2019
- International Conference on Stem Cells and Regenerative Medicine - Hoover Sun - November 5th, 2019
- Global Cancer Stem Cell Market Forecast to 2024 by Types, Application and by Regions - Exchange 99 - November 5th, 2019
- Lymphatic System Discovered To Play Key Role in Hair Regeneration - Technology Networks - November 5th, 2019
- Stem cell transplants approved for people with MS in Scotland - MS Trust - November 5th, 2019
- Johns Hopkins professor to lecture on interplay of secular bioethics, religion as part of Honors Colloquium - URI Today - November 5th, 2019
- Russell Brand Defends Lewis Hamiltons Vegan Hypocrisy and It Will Make You Think - LIVEKINDLY - November 5th, 2019
- Latest Report on Stem Cell Banking Market to Drive Amazing Growth by 2025 | Cord Blood Registry (CBR) Systems - News Hours Today - November 5th, 2019
- Global Stem Cell Cartilage Regeneration Market 2019, Trend, CAGR Status, Growth, Analysis and Forecast to 2024 - BeetleVersion - November 5th, 2019
- The House of Lords is needed to protect democracy now more than ever - The Independent - November 3rd, 2019
- Late-Term Abortion and an Election in Virginia - Newsmax - October 31st, 2019
- AIVITA Biomedical Announces Publication Detailing Immune Mechanisms Leading to Complete Remission of Measurable Metastatic Melanoma in Patient Treated... - October 31st, 2019
- CHS teacher enjoys prepping students for life out on their own - Albuquerque Journal - October 31st, 2019